Search

Search Results

1. TMTV-Net: fully automated total metabolic tumor volume segmentation in lymphoma PET/CT images — a multi-center generalizability analysis

   Purpose

   Total metabolic tumor volume (TMTV) segmentation has significant value enabling quantitative imaging biomarkers for lymphoma management. In...

   Fereshteh Yousefirizi, Ivan S. Klyuzhin, ... Arman Rahmim in European Journal of Nuclear Medicine and Molecular Imaging

   Article 08 February 2024
   

2. Disseminated Invasive Mucormycosis Infection Following Autologous Stem Cell Transplantation for Diffuse Large B-Cell Lymphoma

   Invasive fungal infections (IFI) are challenging to predict, diagnose and treat, and are associated with a particularly high mortality among patients...

   Edward R. Scheffer Cliff, Gemma Reynolds, Andrew Grigg in Clinical Hematology International

   Article Open access 08 February 2023
   

3. Imaging of Nontraumatic Splenic Emergencies

   Acute abnormalities in the spleen are frequently traumatic but also include nontraumatic entities which can be potentially life-threatening if not...

   Maria Zulfiqar, Vincent M. Mellnick in Atlas of Emergency Imaging from Head-to-Toe

   Living reference work entry 2021
   

4. Differential diagnosis of lymphoma with ¹⁸F-FDG PET/CT in patients with fever of unknown origin accompanied by lymphadenopathy

   Purpose

   To investigate the value of ¹⁸ F-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography ( ¹⁸ F-FDG PET/CT) in the...

   Jia Chen, Dong Xu, ... Jian-**n Song in Journal of Cancer Research and Clinical Oncology

   Article Open access 08 March 2023
   

5. Targeting the MYC interaction network in B-cell lymphoma via histone deacetylase 6 inhibition

   Overexpression of MYC is a genuine cancer driver in lymphomas and related to poor prognosis. However, therapeutic targeting of the transcription...

   René Winkler, Ann-Sophie Mägdefrau, ... Christian Kosan in Oncogene

   Article Open access 06 September 2022
   

6. Inhibition of choline metabolism in an angioimmunoblastic T-cell lymphoma preclinical model reveals a new metabolic vulnerability as possible target for treatment

   Background

   Angioimmunoblastic T-cell lymphoma (AITL) is a malignancy with very poor survival outcome, in urgent need of more specific therapeutic...

   Adrien Krug, Marie Tosolini, ... Els Verhoeyen in Journal of Experimental & Clinical Cancer Research

   Article Open access 06 February 2024
   

7. Research progress on epigenetics of small B-cell lymphoma

   Small B-cell lymphoma is the classification of B-cell chronic lymphoproliferative disorders that include chronic lymphocytic leukaemia/small...

   Xueqin Ruan, Rong Zhang, ... Hongling Peng in Clinical and Translational Oncology

   Article 25 March 2022
   

8. Risk assessment and prognostic analysis of patients with splenic infarction in emergency department: a multicenter retrospective study

   Splenic infarction is a thromboembolic disease that is frequently missed in acute settings. Previous reviews were rarely presented from a clinical...

   Chieh-Ching Yen, Chih-Kai Wang, ... Chung-Hsien Chaou in Scientific Reports

   Article Open access 02 November 2021
   

9. Enteropathy-Associated T-Cell Lymphoma: Epidemiology, Natural History, and Management in the Current Era

   Celiac disease (CeD) is a chronic autoimmune enteropathy which is seen in genetically predisposed individuals (HLA DQ2 and HLA DQ8 positive) as a...

   Rajeev Sandal, Ashish Chauhan, ... Asheesh Kumar in

   Chapter 2023
   

10. Fluorescence-guided laparoscopic lymph node biopsy for lymphoma: the FLABILY study

    Abstract

    To date, no reports have indicated laparoscopic lymph node biopsies using Indocyanine green (ICG) in cases of lymphoproliferative disease....

    Marco Casaccia, Giovanni Alemanno, ... Franco De Cian in Updates in Surgery

    Article Open access 14 June 2024
    

11. Splenic Marginal Zone Lymphoma and Other Small B-Cell Lymphomas

    Most splenic small B-cell lymphomas represent secondary involvement by systemic lymphomas. Primary splenic small B-cell lymphoma is rare. Splenic...

    Haipeng Shao in Diagnostic Pathology of Hematopoietic Disorders of Spleen and Liver

    Chapter 2020
    

12. High prevalence of past hepatitis B virus infection in diffuse large B cell lymphoma: a retrospective study from Italy

    Studies from high endemic areas, mostly China, indicate that surface antigen positive (HBsAg ^pos ) chronic hepatitis B virus (HBV) infection is...

    Marcella Visentini, Andrea Pica, ... Alessandro Pulsoni in Annals of Hematology

    Article Open access 31 August 2023

13. Retrospective analysis of diagnosis and therapeutic strategies for patients with hepatosplenic T cell lymphoma

    Hepatosplenic T cell lymphoma (HSTCL) is a rare and aggressive lymphoma with no standard treatment and poor treatment response. From 2001–2021, 20...

    Youngkyung Jeon, Sang Eun Yoon, ... Won Seog Kim in Annals of Hematology

    Article 16 May 2023
    

14. A phase I/II study of 10-min dosing of bendamustine hydrochloride (rapid infusion formulation) in patients with previously untreated indolent B-cell non-Hodgkin lymphoma, mantle cell lymphoma, or relapsed/refractory diffuse large B-cell lymphoma in Japan

    Purpose

    This phase I/II clinical study was conducted to examine the safety, tolerability, pharmacokinetics, and efficacy of 10-min dosing of...

    Kenichi Ishizawa, Masahiro Yokoyama, ... Michinori Ogura in Cancer Chemotherapy and Pharmacology

    Article Open access 07 July 2022
    

15. Feasibility of circulating tumor DNA analysis in dogs with naturally occurring malignant and benign splenic lesions

    Comparative studies of naturally occurring canine cancers have provided new insight into many areas of cancer research. Development and validation of...

    Patricia Filippsen Favaro, Samuel D. Stewart, ... Muhammed Murtaza in Scientific Reports

    Article Open access 15 April 2022
    

16. Cardiovascular screening outcomes in the Dutch survivorship care program for Hodgkin lymphoma survivors

    Purpose

    Hodgkin lymphoma (HL) survivors are at increased risk of cardiovascular disease (CVD) due to former lymphoma treatment. In 2013,...

    Eline M. J. Lammers, Annelies Nijdam, ... Berthe M. P. Aleman in Journal of Cancer Survivorship

    Article 23 April 2024
    

17. A case of multidrug-resistant miliary tuberculosis mimicking lymphoma: a matter of life or death

    Background

    Tuberculosis (TB) is a systemic infectious disease that is caused by Mycobacterium tuberculosis and which can affect many tissues and...

    Vildan Gursoy, Fahir Ozkalemkas, ... Rıdvan Ali in Bulletin of the National Research Centre

    Article Open access 05 May 2023
    

18. Follicular helper T-cell lymphomas: disease spectrum, relationship with clonal hematopoiesis, and mimics. A report of the 2022 EA4HP/SH lymphoma workshop

    Follicular helper T-cell lymphomas (TFH lymphomas) were discussed in session V of the lymphoma workshop of the European Association for...

    Sarah L Ondrejka, Catalina Amador, ... Laurence de Leval in Virchows Archiv

    Article Open access 27 July 2023
    

19. The combination of early identification, chemotherapy, and autologous stem cell transplantation obtained favorable outcomes in unilateral primary adrenal lymphoma: A case report

    Purpose

    Primary adrenal lymphoma (PAL) is an extremely rare entity, there were few cases have been reported. We report a 52-year-old female with...

    Lu Huang, **ao Shuai, ... Yan Ren in Endocrine

    Article 15 October 2022
    

20. Dihydroartemisinin beneficially regulates splenic immune cell heterogeneity through the SOD3-JNK-AP-1 axis

    The immunomodulatory potential of dihydroartemisinin (DHA) has recently been highlighted; however, the potential mechanism remains to be clarified....

    Yiwei Zhang, Qilong Li, ... Qijun Chen in Science China Life Sciences

    Article 23 February 2022